Investigators analyzed seven molecular datasets of samples from patients with advanced melanoma treated with immune checkpoint inhibitor agents to investigate clinical, genomic, and transcriptomic features of anti-PD-1 response in cutaneous melanoma.
[Cancer Cell]
